title: Induction therapy with an immunomodulatory CD2 antibody does not inhibit allograft vasculopathy after rat heart transplantation.
authors.affiliation: Department of Cardiology, University of Heidelberg, Germany.
authors.forename: T J
authors.initials: TJ
authors.lastname: Dengler
authors.forename: G
authors.initials: G
authors.lastname: Szabo
authors.forename: K
authors.initials: K
authors.lastname: Amann
authors.forename: W
authors.initials: W
authors.lastname: Nottmeyer
authors.forename: C
authors.initials: C
authors.lastname: Vahl
authors.forename: S
authors.initials: S
authors.lastname: Hagl
authors.forename: R
authors.initials: R
authors.lastname: Zimmermann
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018801:CD2 Antigens / Q000276:immunology*; D016516:CD4-CD8 Ratio; D003327:Coronary Disease / Q000473:pathology / Q000517:prevention & control*; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology / Q000473:pathology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D011183:Postoperative Complications / Q000517:prevention & control; D051381:Rats; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D016042:Transplantation, Heterotopic; D014184:Transplantation, Homologous
chemical_list: D000911:Antibodies, Monoclonal; D018801:CD2 Antigens; D007166:Immunosuppressive Agents; C112333:OX-34 monoclonal antibody; D016572:Cyclosporine